Brian Lieser - 04 Dec 2025 Form 4 Insider Report for BELDEN INC. (BDC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Dec 2025, 16:49:17 UTC
Prior SEC filing
04 Dec 2025
Next SEC filing
12 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian E. Anderson, attorney-in-fact for Brian Lieser

Key filing fact

Brian Lieser filed Form 4 for BELDEN INC. (BDC) on 08 Dec 2025.

Key facts

  • This page summarizes Brian Lieser's Form 4 filing for BELDEN INC. (BDC).
  • 10 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 08 Dec 2025, 16:49.

Change

  • Previous filing in this sequence was filed on 04 Dec 2025.
  • Current net transaction value: -$281,607.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001967061 Primary reporting owner

Lieser Brian

Relationship
EVP, Solutions
Address
C/O BELDEN INC., 1 N. BRENTWOOD BLVD., 15TH FLOOR, ST. LOUIS
Signature
/s/ Brian E. Anderson, attorney-in-fact for Brian Lieser
Signature date
08 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDC transaction

Common Stock

Options Exercise

Transaction value
$135,336
Shares
+2,516
Change %
+8.7%
Price
$53.79
Shares after
31,590
Date
04 Dec 2025
Ownership
Direct
Footnotes
F1
BDC transaction

Common Stock

Disposed to Issuer

Transaction value
$212,303
Shares
-1,759
Change %
-5.6%
Price
$120.70
Shares after
29,831
Date
04 Dec 2025
Ownership
Direct
Footnotes
F3
BDC transaction

Common Stock

Options Exercise

Transaction value
$90,641
Shares
+1,210
Change %
+4.1%
Price
$74.91
Shares after
31,041
Date
04 Dec 2025
Ownership
Direct
Footnotes
F1
BDC transaction

Common Stock

Disposed to Issuer

Transaction value
$115,988
Shares
-961
Change %
-3.1%
Price
$120.70
Shares after
30,080
Date
04 Dec 2025
Ownership
Direct
Footnotes
F4
BDC transaction

Common Stock

Options Exercise

Transaction value
$89,094
Shares
+1,225
Change %
+4.1%
Price
$72.73
Shares after
31,305
Date
04 Dec 2025
Ownership
Direct
Footnotes
F1
BDC transaction

Common Stock

Disposed to Issuer

Transaction value
$115,988
Shares
-961
Change %
-3.1%
Price
$120.70
Shares after
30,344
Date
04 Dec 2025
Ownership
Direct
Footnotes
F5
BDC transaction

Common Stock

Sale

Transaction value
$152,400
Shares
-1,270
Change %
-4.2%
Price
$120.00
Shares after
29,074
Date
05 Dec 2025
Ownership
Direct
Footnotes
F6
BDC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
505
Date
04 Dec 2025
Ownership
By 401(k) Plan
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDC transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-1,210
Change %
-100%
Price
$0.000000
Shares after
0
Date
04 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,210
Exercise price
$74.91
Footnotes
F1, F7
BDC transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-1,225
Change %
-100%
Price
$0.000000
Shares after
0
Date
04 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,225
Exercise price
$72.73
Footnotes
F1, F7
BDC transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-2,516
Change %
-100%
Price
$0.000000
Shares after
0
Date
04 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,516
Exercise price
$53.79
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.

Footnote F2

Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.

Footnote F3

This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

Footnote F4

This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

Footnote F5

This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

Footnote F6

The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.

Footnote F7

The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .